000 | 01941 a2200517 4500 | ||
---|---|---|---|
005 | 20250518013217.0 | ||
264 | 0 | _c20190502 | |
008 | 201905s 0 0 eng d | ||
022 | _a1872-7549 | ||
024 | 7 |
_a10.1016/j.bbr.2018.12.013 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAl-Massri, Khaled F | |
245 | 0 | 0 |
_aMesenchymal stem cells therapy enhances the efficacy of pregabalin and prevents its motor impairment in paclitaxel-induced neuropathy in rats: Role of Notch1 receptor and JAK/STAT signaling pathway. _h[electronic resource] |
260 |
_bBehavioural brain research _c03 2019 |
||
300 |
_a303-311 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAcetone _xtoxicity |
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xtoxicity |
650 | 0 | 4 |
_aAntioxidants _xmetabolism |
650 | 0 | 4 |
_aCaspase 3 _xmetabolism |
650 | 0 | 4 |
_aCell- and Tissue-Based Therapy _xmethods |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aHyperalgesia _xphysiopathology |
650 | 0 | 4 |
_aInterleukin-6 _xmetabolism |
650 | 0 | 4 |
_aJanus Kinases _xmetabolism |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMesenchymal Stem Cells _xphysiology |
650 | 0 | 4 |
_aMotor Disorders _xetiology |
650 | 0 | 4 |
_aNerve Growth Factor _xmetabolism |
650 | 0 | 4 |
_aPaclitaxel _xtoxicity |
650 | 0 | 4 |
_aPregabalin _xtherapeutic use |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 |
_aReceptor, Notch1 _xmetabolism |
650 | 0 | 4 | _aRotarod Performance Test |
650 | 0 | 4 |
_aSTAT Transcription Factors _xmetabolism |
650 | 0 | 4 |
_aSciatic Neuropathy _xchemically induced |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xmetabolism |
700 | 1 | _aAhmed, Lamiaa A | |
700 | 1 | _aEl-Abhar, Hanan S | |
773 | 0 |
_tBehavioural brain research _gvol. 360 _gp. 303-311 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bbr.2018.12.013 _zAvailable from publisher's website |
999 |
_c29156912 _d29156912 |